[go: up one dir, main page]

DK578887D0 - Antihypertensiva - Google Patents

Antihypertensiva

Info

Publication number
DK578887D0
DK578887D0 DK578887A DK578887A DK578887D0 DK 578887 D0 DK578887 D0 DK 578887D0 DK 578887 A DK578887 A DK 578887A DK 578887 A DK578887 A DK 578887A DK 578887 D0 DK578887 D0 DK 578887D0
Authority
DK
Denmark
Prior art keywords
antihypertensives
certain
relates
enhancement
conjunctive
Prior art date
Application number
DK578887A
Other languages
English (en)
Other versions
DK167209B1 (da
DK578887A (da
Inventor
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK578887D0 publication Critical patent/DK578887D0/da
Publication of DK578887A publication Critical patent/DK578887A/da
Application granted granted Critical
Publication of DK167209B1 publication Critical patent/DK167209B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK578887A 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension DK167209B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92778586A 1986-11-05 1986-11-05
US92778586 1986-11-05

Publications (3)

Publication Number Publication Date
DK578887D0 true DK578887D0 (da) 1987-11-04
DK578887A DK578887A (da) 1988-05-06
DK167209B1 DK167209B1 (da) 1993-09-20

Family

ID=25455252

Family Applications (1)

Application Number Title Priority Date Filing Date
DK578887A DK167209B1 (da) 1986-11-05 1987-11-04 Synergistisk aktivt praeparat til behandling af hypertension

Country Status (11)

Country Link
EP (1) EP0268146B1 (da)
JP (1) JP2612175B2 (da)
KR (1) KR950013758B1 (da)
AT (1) ATE59781T1 (da)
DE (1) DE3767287D1 (da)
DK (1) DK167209B1 (da)
ES (1) ES2036560T3 (da)
GR (1) GR3001375T3 (da)
IE (1) IE59905B1 (da)
PH (1) PH23818A (da)
ZA (1) ZA878182B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2270517T3 (es) * 1997-05-19 2007-04-01 Zonagen, Inc. Terapia de combinacion para modular la respuesta sexual humana.
SK8782000A3 (en) * 1997-12-16 2002-03-05 Pfizer Prod Inc Combination, composition and kits effective for the treatment of impotence
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
US20130274245A1 (en) * 2012-04-11 2013-10-17 Jan BLUMENSTEIN Composition For Prevention of Vasoactivity in the Treatment of Blood Loss and Anemia
CA2915445C (en) 2013-07-19 2024-04-23 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EA201992230A1 (ru) 2013-12-04 2020-02-28 Бёрингер Ингельхайм Ветмедика Гмбх Улучшенные фармацевтические композиции пимобендана
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130647A (en) * 1977-07-08 1978-12-19 Pfizer Inc. Methods for treating congestive heart failure and ischemic heart disease
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation

Also Published As

Publication number Publication date
JPS63132837A (ja) 1988-06-04
KR880005934A (ko) 1988-07-21
IE872975L (en) 1988-05-05
JP2612175B2 (ja) 1997-05-21
ZA878182B (en) 1988-05-02
ES2036560T3 (es) 1993-06-01
DE3767287D1 (de) 1991-02-14
GR3001375T3 (en) 1992-09-11
EP0268146A1 (en) 1988-05-25
IE59905B1 (en) 1994-04-20
KR950013758B1 (ko) 1995-11-15
DK167209B1 (da) 1993-09-20
PH23818A (en) 1989-11-23
ATE59781T1 (de) 1991-01-15
DK578887A (da) 1988-05-06
EP0268146B1 (en) 1991-01-09

Similar Documents

Publication Publication Date Title
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
FI864775A7 (fi) Valoa säteilevä kangas lääketieteelliseen hoitoon.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DE3674593D1 (de) Medizinische zusammensetzung.
DK578887A (da) Antihypertensiva
ES2037670T3 (es) Procedimiento para la preparacion de complejos de (2,2-bis(aminometil)-1,3-propanodiol-n,n') platino.
ATE39357T1 (de) Derivate von griseolicsaeure und ihre verwendung.
DK462687A (da) Forbindelse til behandling af retrovirusinfektioner.
IT1207498B (it) Procedimento per la preparazione di composizioni plasto-elastomeriche poliolefiniche, mediante vulcanizzazione dinamica.
NO890046D0 (no) Disubstituerte pyridiner.
ES2059457T3 (es) Utilizacion de bezafibrato para el tratamiento de la diabetes.
ES2014438B3 (es) Derivados del acido 2-fosfonobutano-1,2,4tricarboxilico, como agentes emulsivos.
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
NO871639L (no) Vertikal arkstabler.
IT8621410A0 (it) Composizione per il miglioramento del candeggio.
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
ES2024503B3 (es) Mejoras en, o relacionadas con, el reforzamiento del terreno.
NO165917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.
SE7909788L (sv) Sett att framstella en antihemofilifaktor
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
ATE69609T1 (de) Cardiotonische imidazolylphenylpyrrol-2-one.
ES2003844A4 (es) Medio de tratamiento de cabello con un contenido de acido de almandras d,l
KR950009091B1 (en) Antidepressants containing 1-benzyl-aminoalkyl-pyrrolidinones

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired